Bloodstream infections in critically ill patients with COVID-19.

Daniele Roberto GiacobbeDenise BattagliniLorenzo BallIole BrunettiBianca BruzzoneGiulia CoddaFrancesca CreaAndrea De MariaChiara DentoneAntonio Di BiagioGiancarlo IcardiLaura MagnascoAnna MarcheseMalgorzata MikulskaAndrea OrsiNicolò PatronitiChiara RobbaAlessio SignoriLucia TaramassoAntonio VenaPaolo PelosiMatteo Bassetti

Published in: European journal of clinical investigation (2020)

The incidence rate of BSI was high, and the cumulative risk of developing BSI increased with ICU stay. Further study will clarify if the increased risk of BSI we detected in COVID-19 patients treated with anti-inflammatory drugs is outweighed by the benefits of reducing any possible pro-inflammatory dysregulation induced by SARS-CoV-2.

Keyphrases

sars cov
anti inflammatory drugs
coronavirus disease
respiratory syndrome coronavirus
intensive care unit
risk factors
mechanical ventilation